Andrew P. Degnan

4 Patents

• US125706712026

  Substituted Oxoisoindoline Compounds for the Treatment of Cancer

  Bristol-myers Squibb Company

  0 cites
• US124862672025

  Imidazo[1,2-a]pyridine and [1,2,4]triazolo[1,5-a]pyridine Derivatives as TLR9 Inhibitors for the Treatment of Fibrosis

  Bristol-myers Squibb Company

  0 cites
• USRE0497352023

  Oxazolidinones as Modulators of MGLUR5

  Bristol-myers Squibb Company

  0 cites
• US115488702023

  Compounds Useful as Inhibitors of Helios Protein

  Bristol-myers Squibb Company

  0 cites